Condition
Intrahepatic Cholestasis
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed2
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06781242Recruiting
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
NCT02633384Phase 4TerminatedPrimary
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
NCT01576458Phase 3CompletedPrimary
Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
NCT01381939CompletedPrimary
Induction of Labor in Intrahepatic Cholestasis of Pregnancy
Showing all 4 trials